U.S. Peptide Synthesis Market was valued at USD 239.15 Million in 2025 and is expected to reach USD 563.82 Million by 2035 due to the concentration of pharmaceutical and biotech firms investing in ...

Synthesis Wealth Planning is a Kestra Financial-affiliated wealth management firm headquartered in Morristown, N.J.

The latest addition brings an advisory team that had been affiliated with Kestra Financial, a sister firm of Bluespring.

Codexis, a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, shared new advances in RNA therapeutic manufacturing at TIDES USA ...

Bluespring Wealth (“Bluespring”), a leading acquirer of independent RIAs and hybrid wealth management firms, today announced the acquisition of Kestra Financial-affiliated firm Synthesis Wealth ...

BCC Research highlights how protein therapeutics, cell-free systems, high-throughput technologies, personalized medicine and ...

The deal marks Bluespring's fifth acquisition this year and follows nine deals representing more than $6 billion in AUM in ...

Sino Biological, Inc., a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02) , a cutting-edge solution ...

A research team led by Professor Sohee Jeong at Sungkyunkwan University has uncovered a key chemical pathway for the ...

Controlling chemical reactions more efficiently and sustainably New synthesis method enables targeted modifications to ...

This post was updated May 13 at 12:19 a.m. Synthesis Dance is ready to return to the spotlight at Spring Sing 2026. The ...

Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP ScreeningHOUSTON, May 19, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global ...